Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy

Digestive Diseases and Sciences

Volumn 51, Issue 11, 2006, Pages 2081-2086

  Choi, Seok Reyol ^a,b   Jang, Jin Seok ^a   Lee, Jong Hun ^a   Roh, Myung Hwan ^a   Kim, Min Chan ^a   Lee, Won Sup ^c   Qureshi, Waqar ^b  

^a Dong A University   (South Korea)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Gyeongsang National University   (South Korea)

Author keywords

Gastric cancer; Recurrence; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITONEUM; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER;

ADULT; AGED; CA-19-9 ANTIGEN; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33751534935     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9166-5     Document Type: Article

References (25)

1. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T (1992) Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87:321-325
2. Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD (2004) The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 51:1544-1547
3. Lukinac L, Bolanca A, Nothig-Hus D, Kusic Z (1997) Follow-up of patients with gastrointestinal cancer by tumor marker determination. Acta Med Croatica 51:73-77
4. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H (2003) Tumor Marker Committee: the usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 6:142-145
5. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, Matsumoto Y (2002) Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19:359-365
6. Hansen HJ, Snyder JJ, Miller E, Vandevoorde JP, Miller ON, Hines LR, Burns JJ (1974) Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol 5:139-147
7. Reynoso G, Chu TM, Holyoke D, Cohen E, Nemoto T, Wang JJ, Chuang J, Guinan P, Murphy GP (1972) Carcinoembryonic antigen in patients with different cancers. JAMA 220:361-365
8. Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K, Ishikawa H (2001) Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer. Eur J Surg Oncol 27:731-739
9. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F (2001) Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 181:16-19
10. Nanashima A, Yamaguchi H, Sawai T, Yamaguchi E, Kidogawa H, Matsuo S, Yasutake T, Tsuji T, Jibiki M, Nakagoe T, Ayabe H (2001) Prognostic factors in hepatic metastases of colorectal carcinoma. Dig Dis Sci 46:1623-1628
11. Mori M, Sakaguchi H, Akazawa K, Tsuneyoshi M, Sueishi K, Sugimachi K (1995) Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol 26:504-508
12. Nakane Y, Okamura H, Koyanagi N, Boku T, Okusa T, Tanaka K, Hioki K (1994) Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 73:2703-2708
13. Choi JH, Lee SY, Son HY, Hong ES, Kim HJ, Park SY, Hwang MG, Shim KS (1996) Determination of preoperative serum CEA level in curatively resected gastric cancer. J Korean Cancer Assoc 28:1050-1054
14. Shimizu N, Wakatsuki T, Murakami A, Yoshioka H, Hamazoe R, Kanayama H, Maeta M, Koga S (1987) Carcinoembryonic antigen in gastric cancer patients. Oncology 44:240-244
15. Maehara Y, Sugimachi K, Akagi M, Kakegawa T, Shimazu H, Tomita M (1990) Serum carcinoembryonic antigen level increases correlate with tumor progression in patients with differentiated gastric carcinoma following noncurative resection. Cancer Res 50:3952-3955
16. Santeusanio G, Peronace L, Castagna G, De Muro G, Santi D, D'Orazio A, Amanti C, Midiri G, Campisi C, D'Ambra G (1988) Immunohistochemical study of carcinoembryonic antigen (CEA) in gastric tumor: correlation with preoperative serum levels, histologic type, and grade of anaplasia of the tumor. J Surg Oncol 37:13-19
17. Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H (1982) Gastrointestinal cancer associated antigen in immunoperoxidase assay. Cancer Res 42:4820-4823
18. Beretta E, Malesci A, Zerbi A, Mariani A, Carlucci M, Bonato C, Ferrari AM, Di Carlo V (1987) Serum CA 19-9 in the post-surgical follow-up of patients with pancreatic cancer. Cancer 60:2428-2431
19. Herlyn M, Sears HF, Steplewski Z, Koprowski H (1982) Monoclonal antibody detection of a circulating tumor associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol 2:135-140
20. Imamura Y, Yasutake K, Yoshimura Y, Oya M, Matsushita K, Tokisue M, Ohno S, Masuda T (1990) The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer. Gan To Kagaku Ryoho 17:1501-1507
21. Ritts RE Jr, Del Villano BC, Go VL, Herberman RB, Klug TL, Zurawski VR Jr (1985) Initial clinical evaluation of an immunoradiometric for CA 19-9 using the NCI serum bank. Int J Cancer 33:339-345
22. Yook JH, Kim BS, Kim YH, Suh BS, Kim WS, Oh ST, Park KC (1999) Diagnostic value of tumor markers in stomach cancer. J Korean Cancer Assoc 31:1094-1100
23. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T (1996) The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol 91:49-53
24. Nishimura H, Okamoto Y, Takahashi M, Fujita T (1976) Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer. Gastroenterology 71:497-499
25. Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N, Masuda M, Mori S (1989) Comparison of serum assays for Tag-72, CA 19-9, and CEA in gastrointestinal carcinoma patients. Jpn J Clin Oncol 19:242-248